Co-Diagnostics (NASDAQ:CODX) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Co-Diagnostics missed estimated earnings by -150.0%, reporting an EPS of $-0.5 versus an estimate of $-0.2.
Revenue was up $2.15 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 10.0% drop in the share price the next day.
Here's a look at Co-Diagnostics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.24 | -0.22 | -0.15 |
| EPS Actual | -0.20 | -0.31 | -0.20 | -0.19 |
| Revenue Estimate | 200K | 500K | 1.10M | 5.50M |
| Revenue Actual | 2.46M | 197K | 601K | 1.40M |
To track all earnings releases for Co-Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.